A promising novel medication for dry eye treatment is the Diquafosol ophthalmic solution 3% which stimulated fluid secretion from conjunctival epithelial cells and mucin secretion from the conjunctival goblet cells. Here, MUC5AC is linked to Keratoconjunctivitis sicca.